Acute	acute	O	O	O	O
cholestatic	cholestatic	O	O	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
after	after	O	O	O	O
exposure	exposure	O	O	O	O
to	to	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
report	report	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
acute	acute	O	O	O	O
cholestatic	cholestatic	O	O	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
following	following	O	O	O	O
exposure	exposure	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
inhalational	inhalational	O	O	O	O
anesthetic	anesthetic	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

CASE	case	O	O	O	O
SUMMARY	summary	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
70-year-old	70-year-old	O	O	O	O
healthy	healthy	O	O	O	O
woman	woman	O	O	O	O
from	from	O	O	O	O
Iraq	iraq	O	O	O	O
developed	developed	O	O	O	O
acute	acute	O	O	O	O
cholestatic	cholestatic	O	O	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
3	3	O	O	O	O
weeks	weeks	O	O	O	O
following	following	O	O	O	O
repair	repair	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
right	right	O	O	O	O
rotator	rotator	O	O	O	O
cuff	cuff	O	O	O	O
under	under	O	O	O	O
general	general	O	O	O	O
anesthesia	anesthesia	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
was	was	O	O	O	O
no	no	O	O	O	O
evidence	evidence	O	O	O	O
for	for	O	O	O	O
viral	viral	O	O	O	O
,	,	O	O	O	O
autoimmune	autoimmune	O	O	O	O
,	,	O	O	O	O
or	or	O	O	O	O
metabolic	metabolic	O	O	O	O
causes	causes	O	O	O	O
of	of	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

No	no	O	O	O	O
other	other	O	O	O	O
medications	medications	O	O	O	O
were	were	O	O	O	O
involved	involved	O	O	O	O
except	except	O	O	O	O
for	for	O	O	O	O
dipyrone	dipyrone	O	O	OTHERS	I
for	for	O	O	O	O
analgesia	analgesia	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
alanine	alanine	CHEMICALS	O	OTHERS	I
aminotransferase	aminotransferase	O	O	O	O
was	was	O	O	O	O
elevated	elevated	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
peak	peak	O	O	O	O
concentration	concentration	O	O	O	O
of	of	O	O	O	O
1533	1533	O	O	O	O
U/L	u/l	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
serum	serum	O	O	O	O
bilirubin	bilirubin	CHEMICALS	O	OTHERS	I
reached	reached	O	O	O	O
a	a	O	O	O	O
peak	peak	O	O	O	O
of	of	O	O	O	O
17.0	17.0	O	O	O	O
mg/dL.	mg/dl.	O	O	O	O
There	there	O	O	O	O
was	was	O	O	O	O
slow	slow	O	O	O	O
improvement	improvement	O	O	O	O
over	over	O	O	O	O
4	4	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

Accidental	accidental	O	O	O	O
reexposure	reexposure	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
to	to	O	O	O	O
dipyrone	dipyrone	O	O	OTHERS	I
was	was	O	O	O	O
uneventful	uneventful	O	O	O	O
.	.	O	O	O	O

DISCUSSION	discussion	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
clinical	clinical	O	O	O	O
and	and	O	O	O	O
histologic	histologic	O	O	O	O
picture	picture	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
case	case	O	O	O	O
resembles	resembles	O	O	O	O
halothane	halothane	CHEMICALS	DISEASE	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
has	has	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
mortality	mortality	O	O	O	O
rate	rate	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
Isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
common	common	O	O	O	O
anesthetic	anesthetic	O	O	O	O
agent	agent	O	O	O	O
,	,	O	O	O	O
can	can	O	O	O	O
cause	cause	O	O	O	O
severe	severe	O	O	O	O
cholestatic	cholestatic	O	O	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

